PROVA Innovations

PROVA Innovations occupies a focused niche at the intersection of wearable medical devices, digital health, and gait rehabilitation. Its described smart insoles are aimed at people with early- and mid-stage knee and hip osteoarthritis, while its website messaging extends to in-home gait training and neuromuscular rehabilitation. The stated differentiator is the use of wearable biofeedback and coaching during everyday activity, with the goal of supporting practice between physiotherapy visits. This positions the offering around rehabilitation outside a clinic rather than solely around assessment or passive monitoring. It also does not establish regulatory status, clinical validation, pricing, distribution, or adoption. The three recorded funding rounds are grants totaling $467,335, rather than disclosed equity financing, and the employee range is 1–10. These indicators describe a small, grant-funded company operating in a specialized medical and health-care category, but do not by themselves establish market share or commercial traction.

PROVA Innovations was founded in 2015 and has three recorded grants: $39,335 USD from The Arthritis Society on Apr 22, 2022, $30,000 from i.d.e.a. Fund on Jun 14, 2023, and $398,000 from FABrIC. on Jun 26, 2025. The latest grant is a substantial increase over the earlier disclosed amounts and brings recorded funding to $467,335, making 2025 a clear funding inflection point. The stated product focus is smart insoles for gait rehabilitation, while website materials describe in-home training with biofeedback and coaching. Consequently, the evidence supports continued development activity through grant funding, but not a confident conclusion about revenue growth, customer adoption, or expansion.